Smad7 and Colorectal Carcinogenesis: A Double-Edged Sword
Colorectal carcinogenesis is a complex process in which many immune and non-immune cells and a huge number of mediators are involved. Among these latter factors, Smad7, an inhibitor of the transforming growth factor (TGF)-β1 signaling that has been involved in the amplification of the infla...
Main Authors: | Edoardo Troncone, Giovanni Monteleone |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/5/612 |
Similar Items
-
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer
by: Edoardo Troncone, et al.
Published: (2018-06-01) -
Therapeutic Implications of TGFβ in Cancer Treatment: A Systematic Review
by: Verónica Gómez-Gil
Published: (2021-01-01) -
Celastrol inhibits colorectal cancer through TGF-β1/Smad signaling
by: Jiang Z, et al.
Published: (2019-01-01) -
Involvement of Smad7 in Inflammatory Diseases of the Gut and Colon Cancer
by: Edoardo Troncone, et al.
Published: (2021-04-01) -
The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis
by: Carmine Stolfi, et al.
Published: (2013-12-01)